healthcare providers media publications & posters WE ARE KIADIS OUR RESEARCH FOCUS FOR INVESTORS KIADIS NEWS CAREERS Pages Careers Contact Cookies For investors Healthcare providers Home page Kiadis news Legal disclaimers Locations Media Our research focus Patient & caregivers Privacy Publications & posters Season’s Greetings Sitemap Social Media Guidelines We are Kiadis LOCATIONS LEGAL DISCLAIMERS COOKIES CONTACT PRIVACY SITEMAP CODE OF ETHICS © Copyright 2021 Kiadis Pharma

healthcare providers media publications & posters WE ARE KIADIS OUR RESEARCH FOCUS FOR INVESTORS KIADIS NEWS CAREERS Clinical Trials for K-NK Therapies K-NK002 is an investigational product of Kiadis Pharma and safety and efficacy has not been established by any jurisdiction or agency. We are developing our products in a tightly regulated environment of clinical studies that are reviewed and approved by the national respective authorities to establish a maximum safety level for patients. Currently, therefore, access to our investigational cell therapy is limited to patients meeting the eligibility criteria of our clinical trials. Upcoming Clinical Trial: K-NK002 A phase 2 study, NCT04395092, evaluating haplo-identical NK cells to prevent post-transplant relapse in AML and MDS. This study was designed based on promising clinical proof-of-concept data from MD Anderson Cancer Center showing a Complete Remission (CR) rate of 69% in contrast to historical CR rates of 20-26%.2 K-NK002 will be conducted in collaboration with the Bone Marrow Transplant Clinical Trial Network (BMT CTN), which consists of the premier transplant centers in the United States.3 Upcoming Clinical Trial: K-NK003 A phase 1 study will begin in 2020 evaluating NK cells as a treatment for patients with relapse and refractory acute myeloid leukemia (AML). Pre-Clinical Programs: Kiadis has a number of programs evaluating its K-NK-cell therapies for the treatment of hematologic and solid cancers. For all trials If you are a medical professional and would like information about becoming an investigator for one of our clinical trials, please contact clinicaltrials@kiadis.com UPCOMING TRIALS If you are a medical professional and would like information about becoming an investigator for one of our clinical trials, please contact clinicaltrials@kiadis.com LOCATIONS LEGAL DISCLAIMERS COOKIES CONTACT PRIVACY SITEMAP CODE OF ETHICS © Copyright 2021 Kiadis Pharma